nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—CYP3A4—type 2 diabetes mellitus	0.246	1	CbGaD
Topotecan—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0546	0.118	CbGbCtD
Topotecan—ABCG2—Glyburide—type 2 diabetes mellitus	0.05	0.108	CbGbCtD
Topotecan—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0487	0.105	CbGbCtD
Topotecan—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0352	0.0762	CbGbCtD
Topotecan—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0327	0.0708	CbGbCtD
Topotecan—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0292	0.0631	CbGbCtD
Topotecan—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0267	0.0578	CbGbCtD
Topotecan—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0242	0.0524	CbGbCtD
Topotecan—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0233	0.0505	CbGbCtD
Topotecan—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0211	0.0457	CbGbCtD
Topotecan—ABCB1—Glyburide—type 2 diabetes mellitus	0.018	0.039	CbGbCtD
Topotecan—ABCB1—Losartan—type 2 diabetes mellitus	0.0165	0.0357	CbGbCtD
Topotecan—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.016	0.0346	CbGbCtD
Topotecan—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0153	0.0332	CbGbCtD
Topotecan—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0153	0.0332	CbGbCtD
Topotecan—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0145	0.0314	CbGbCtD
Topotecan—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0108	0.0234	CbGbCtD
Topotecan—CYP3A4—Losartan—type 2 diabetes mellitus	0.00988	0.0214	CbGbCtD
Topotecan—Irinotecan—ABCC2—type 2 diabetes mellitus	0.00212	0.547	CrCbGaD
Topotecan—TOP1MT—adipose tissue—type 2 diabetes mellitus	0.00209	0.13	CbGeAlD
Topotecan—TOP1—islet of Langerhans—type 2 diabetes mellitus	0.00173	0.108	CbGeAlD
Topotecan—TOP1—retina—type 2 diabetes mellitus	0.00148	0.092	CbGeAlD
Topotecan—TOP1MT—liver—type 2 diabetes mellitus	0.00147	0.0912	CbGeAlD
Topotecan—TOP1—nephron tubule—type 2 diabetes mellitus	0.00139	0.0866	CbGeAlD
Topotecan—TOP1—pancreas—type 2 diabetes mellitus	0.00122	0.0756	CbGeAlD
Topotecan—TOP1—cortex of kidney—type 2 diabetes mellitus	0.00119	0.0741	CbGeAlD
Topotecan—TOP1—adipose tissue—type 2 diabetes mellitus	0.0011	0.0686	CbGeAlD
Topotecan—Irinotecan—CYP3A4—type 2 diabetes mellitus	0.000935	0.242	CrCbGaD
Topotecan—Irinotecan—ALB—type 2 diabetes mellitus	0.000816	0.211	CrCbGaD
Topotecan—TOP1—liver—type 2 diabetes mellitus	0.000773	0.0481	CbGeAlD
Topotecan—ABCG2—nephron tubule—type 2 diabetes mellitus	0.000494	0.0307	CbGeAlD
Topotecan—ABCG2—adipose tissue—type 2 diabetes mellitus	0.000391	0.0243	CbGeAlD
Topotecan—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000303	0.0188	CbGeAlD
Topotecan—CYP3A4—kidney—type 2 diabetes mellitus	0.000302	0.0188	CbGeAlD
Topotecan—ABCG2—liver—type 2 diabetes mellitus	0.000274	0.0171	CbGeAlD
Topotecan—ABCB1—retina—type 2 diabetes mellitus	0.000259	0.0161	CbGeAlD
Topotecan—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000244	0.0151	CbGeAlD
Topotecan—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000219	0.0136	CbGeAlD
Topotecan—ABCB1—kidney—type 2 diabetes mellitus	0.000214	0.0133	CbGeAlD
Topotecan—ABCB1—pancreas—type 2 diabetes mellitus	0.000213	0.0132	CbGeAlD
Topotecan—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000208	0.013	CbGeAlD
Topotecan—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000193	0.012	CbGeAlD
Topotecan—CYP3A4—liver—type 2 diabetes mellitus	0.000191	0.0119	CbGeAlD
Topotecan—Back pain—Losartan—type 2 diabetes mellitus	0.000171	0.000816	CcSEcCtD
Topotecan—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000171	0.000816	CcSEcCtD
Topotecan—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000171	0.000816	CcSEcCtD
Topotecan—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.00017	0.000813	CcSEcCtD
Topotecan—Anorexia—Valsartan—type 2 diabetes mellitus	0.00017	0.000811	CcSEcCtD
Topotecan—Muscle spasms—Losartan—type 2 diabetes mellitus	0.00017	0.000811	CcSEcCtD
Topotecan—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000169	0.00081	CcSEcCtD
Topotecan—Chest pain—Metformin—type 2 diabetes mellitus	0.000169	0.000809	CcSEcCtD
Topotecan—Myalgia—Metformin—type 2 diabetes mellitus	0.000169	0.000809	CcSEcCtD
Topotecan—Malaise—Irbesartan—type 2 diabetes mellitus	0.000169	0.000808	CcSEcCtD
Topotecan—Headache—Pioglitazone—type 2 diabetes mellitus	0.000168	0.000805	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000168	0.000803	CcSEcCtD
Topotecan—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000168	0.000802	CcSEcCtD
Topotecan—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000167	0.0008	CcSEcCtD
Topotecan—Discomfort—Metformin—type 2 diabetes mellitus	0.000167	0.000799	CcSEcCtD
Topotecan—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000167	0.000799	CcSEcCtD
Topotecan—Nausea—Glipizide—type 2 diabetes mellitus	0.000167	0.000796	CcSEcCtD
Topotecan—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000166	0.000796	CcSEcCtD
Topotecan—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000166	0.000793	CcSEcCtD
Topotecan—Constipation—Gliclazide—type 2 diabetes mellitus	0.000166	0.000792	CcSEcCtD
Topotecan—Pain—Gliclazide—type 2 diabetes mellitus	0.000166	0.000792	CcSEcCtD
Topotecan—Rash—Glimepiride—type 2 diabetes mellitus	0.000165	0.000789	CcSEcCtD
Topotecan—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000165	0.000788	CcSEcCtD
Topotecan—Rash—Sitagliptin—type 2 diabetes mellitus	0.000165	0.000786	CcSEcCtD
Topotecan—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000164	0.000786	CcSEcCtD
Topotecan—Headache—Glimepiride—type 2 diabetes mellitus	0.000164	0.000784	CcSEcCtD
Topotecan—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000164	0.000783	CcSEcCtD
Topotecan—Cough—Irbesartan—type 2 diabetes mellitus	0.000164	0.000782	CcSEcCtD
Topotecan—Headache—Sitagliptin—type 2 diabetes mellitus	0.000164	0.000781	CcSEcCtD
Topotecan—Anaemia—Losartan—type 2 diabetes mellitus	0.000163	0.00078	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000162	0.000776	CcSEcCtD
Topotecan—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000162	0.000772	CcSEcCtD
Topotecan—Angioedema—Losartan—type 2 diabetes mellitus	0.000161	0.000771	CcSEcCtD
Topotecan—Infection—Metformin—type 2 diabetes mellitus	0.000161	0.00077	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.00016	0.000766	CcSEcCtD
Topotecan—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00016	0.000764	CcSEcCtD
Topotecan—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00016	0.000764	CcSEcCtD
Topotecan—Chest pain—Irbesartan—type 2 diabetes mellitus	0.00016	0.000763	CcSEcCtD
Topotecan—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.00016	0.000763	CcSEcCtD
Topotecan—Myalgia—Irbesartan—type 2 diabetes mellitus	0.00016	0.000763	CcSEcCtD
Topotecan—Malaise—Losartan—type 2 diabetes mellitus	0.000159	0.000761	CcSEcCtD
Topotecan—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000159	0.00076	CcSEcCtD
Topotecan—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000159	0.00076	CcSEcCtD
Topotecan—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000159	0.000759	CcSEcCtD
Topotecan—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000159	0.000759	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000159	0.000758	CcSEcCtD
Topotecan—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000159	0.000758	CcSEcCtD
Topotecan—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000158	0.000755	CcSEcCtD
Topotecan—Leukopenia—Losartan—type 2 diabetes mellitus	0.000158	0.000755	CcSEcCtD
Topotecan—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000158	0.000754	CcSEcCtD
Topotecan—Skin disorder—Metformin—type 2 diabetes mellitus	0.000158	0.000753	CcSEcCtD
Topotecan—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000157	0.000751	CcSEcCtD
Topotecan—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000157	0.000749	CcSEcCtD
Topotecan—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000157	0.000749	CcSEcCtD
Topotecan—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000157	0.000749	CcSEcCtD
Topotecan—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000156	0.000746	CcSEcCtD
Topotecan—Nausea—Glimepiride—type 2 diabetes mellitus	0.000156	0.000743	CcSEcCtD
Topotecan—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000155	0.000741	CcSEcCtD
Topotecan—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000155	0.00074	CcSEcCtD
Topotecan—Asthenia—Glyburide—type 2 diabetes mellitus	0.000155	0.00074	CcSEcCtD
Topotecan—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000155	0.00074	CcSEcCtD
Topotecan—Anorexia—Metformin—type 2 diabetes mellitus	0.000155	0.000739	CcSEcCtD
Topotecan—Cough—Losartan—type 2 diabetes mellitus	0.000154	0.000736	CcSEcCtD
Topotecan—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000154	0.000736	CcSEcCtD
Topotecan—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000154	0.000735	CcSEcCtD
Topotecan—Alopecia—Ramipril—type 2 diabetes mellitus	0.000154	0.000734	CcSEcCtD
Topotecan—Fatigue—Valsartan—type 2 diabetes mellitus	0.000154	0.000734	CcSEcCtD
Topotecan—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000153	0.000732	CcSEcCtD
Topotecan—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000153	0.000732	CcSEcCtD
Topotecan—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000153	0.000732	CcSEcCtD
Topotecan—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000153	0.000731	CcSEcCtD
Topotecan—Pruritus—Glyburide—type 2 diabetes mellitus	0.000153	0.00073	CcSEcCtD
Topotecan—Constipation—Valsartan—type 2 diabetes mellitus	0.000152	0.000728	CcSEcCtD
Topotecan—Infection—Irbesartan—type 2 diabetes mellitus	0.000152	0.000727	CcSEcCtD
Topotecan—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000152	0.000726	CcSEcCtD
Topotecan—Fatigue—Orlistat—type 2 diabetes mellitus	0.000152	0.000725	CcSEcCtD
Topotecan—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000151	0.000723	CcSEcCtD
Topotecan—Pain—Orlistat—type 2 diabetes mellitus	0.000151	0.000719	CcSEcCtD
Topotecan—Chest pain—Losartan—type 2 diabetes mellitus	0.00015	0.000718	CcSEcCtD
Topotecan—Myalgia—Losartan—type 2 diabetes mellitus	0.00015	0.000718	CcSEcCtD
Topotecan—Arthralgia—Losartan—type 2 diabetes mellitus	0.00015	0.000718	CcSEcCtD
Topotecan—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00015	0.000718	CcSEcCtD
Topotecan—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00015	0.000717	CcSEcCtD
Topotecan—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.00015	0.000716	CcSEcCtD
Topotecan—Rash—Bromocriptine—type 2 diabetes mellitus	0.000149	0.000712	CcSEcCtD
Topotecan—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000149	0.000711	CcSEcCtD
Topotecan—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000149	0.000711	CcSEcCtD
Topotecan—Discomfort—Losartan—type 2 diabetes mellitus	0.000148	0.00071	CcSEcCtD
Topotecan—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000148	0.000707	CcSEcCtD
Topotecan—Headache—Bromocriptine—type 2 diabetes mellitus	0.000148	0.000707	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000148	0.000706	CcSEcCtD
Topotecan—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000148	0.000706	CcSEcCtD
Topotecan—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000146	0.000697	CcSEcCtD
Topotecan—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000146	0.000696	CcSEcCtD
Topotecan—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000146	0.000696	CcSEcCtD
Topotecan—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000146	0.000695	CcSEcCtD
Topotecan—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000145	0.000693	CcSEcCtD
Topotecan—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000145	0.000691	CcSEcCtD
Topotecan—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000144	0.000688	CcSEcCtD
Topotecan—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000144	0.000688	CcSEcCtD
Topotecan—Infection—Losartan—type 2 diabetes mellitus	0.000143	0.000684	CcSEcCtD
Topotecan—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000143	0.000683	CcSEcCtD
Topotecan—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000143	0.000682	CcSEcCtD
Topotecan—Urticaria—Valsartan—type 2 diabetes mellitus	0.000142	0.000676	CcSEcCtD
Topotecan—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000141	0.000675	CcSEcCtD
Topotecan—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000141	0.000674	CcSEcCtD
Topotecan—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000141	0.000674	CcSEcCtD
Topotecan—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000141	0.000673	CcSEcCtD
Topotecan—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.00014	0.000671	CcSEcCtD
Topotecan—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00014	0.00067	CcSEcCtD
Topotecan—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.00014	0.000669	CcSEcCtD
Topotecan—Fatigue—Metformin—type 2 diabetes mellitus	0.00014	0.000668	CcSEcCtD
Topotecan—Urticaria—Orlistat—type 2 diabetes mellitus	0.00014	0.000668	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000139	0.000667	CcSEcCtD
Topotecan—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000139	0.000666	CcSEcCtD
Topotecan—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000139	0.000665	CcSEcCtD
Topotecan—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000139	0.000665	CcSEcCtD
Topotecan—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000139	0.000665	CcSEcCtD
Topotecan—Constipation—Metformin—type 2 diabetes mellitus	0.000139	0.000663	CcSEcCtD
Topotecan—Angioedema—Ramipril—type 2 diabetes mellitus	0.000138	0.000661	CcSEcCtD
Topotecan—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000137	0.000657	CcSEcCtD
Topotecan—Anorexia—Losartan—type 2 diabetes mellitus	0.000137	0.000656	CcSEcCtD
Topotecan—Vomiting—Glyburide—type 2 diabetes mellitus	0.000137	0.000656	CcSEcCtD
Topotecan—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000137	0.000656	CcSEcCtD
Topotecan—Malaise—Ramipril—type 2 diabetes mellitus	0.000136	0.000652	CcSEcCtD
Topotecan—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000136	0.000652	CcSEcCtD
Topotecan—Rash—Glyburide—type 2 diabetes mellitus	0.000136	0.000651	CcSEcCtD
Topotecan—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000136	0.00065	CcSEcCtD
Topotecan—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000135	0.000647	CcSEcCtD
Topotecan—ABCB1—liver—type 2 diabetes mellitus	0.000135	0.00842	CbGeAlD
Topotecan—Headache—Glyburide—type 2 diabetes mellitus	0.000135	0.000646	CcSEcCtD
Topotecan—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000135	0.000644	CcSEcCtD
Topotecan—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000134	0.000639	CcSEcCtD
Topotecan—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000133	0.000636	CcSEcCtD
Topotecan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000133	0.000634	CcSEcCtD
Topotecan—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000133	0.000634	CcSEcCtD
Topotecan—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000132	0.000632	CcSEcCtD
Topotecan—Cough—Ramipril—type 2 diabetes mellitus	0.000132	0.000631	CcSEcCtD
Topotecan—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000132	0.000631	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000131	0.000627	CcSEcCtD
Topotecan—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000131	0.000627	CcSEcCtD
Topotecan—Constipation—Irbesartan—type 2 diabetes mellitus	0.000131	0.000626	CcSEcCtD
Topotecan—Pain—Irbesartan—type 2 diabetes mellitus	0.000131	0.000626	CcSEcCtD
Topotecan—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00013	0.00062	CcSEcCtD
Topotecan—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000129	0.000618	CcSEcCtD
Topotecan—Urticaria—Metformin—type 2 diabetes mellitus	0.000129	0.000616	CcSEcCtD
Topotecan—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000129	0.000616	CcSEcCtD
Topotecan—Chest pain—Ramipril—type 2 diabetes mellitus	0.000129	0.000616	CcSEcCtD
Topotecan—Myalgia—Ramipril—type 2 diabetes mellitus	0.000129	0.000616	CcSEcCtD
Topotecan—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000128	0.000614	CcSEcCtD
Topotecan—Nausea—Glyburide—type 2 diabetes mellitus	0.000128	0.000613	CcSEcCtD
Topotecan—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000128	0.000613	CcSEcCtD
Topotecan—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000128	0.000613	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000128	0.000612	CcSEcCtD
Topotecan—Asthenia—Valsartan—type 2 diabetes mellitus	0.000128	0.000611	CcSEcCtD
Topotecan—Discomfort—Ramipril—type 2 diabetes mellitus	0.000127	0.000608	CcSEcCtD
Topotecan—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000127	0.000606	CcSEcCtD
Topotecan—Asthenia—Orlistat—type 2 diabetes mellitus	0.000126	0.000604	CcSEcCtD
Topotecan—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000126	0.000603	CcSEcCtD
Topotecan—Pruritus—Valsartan—type 2 diabetes mellitus	0.000126	0.000602	CcSEcCtD
Topotecan—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000125	0.000599	CcSEcCtD
Topotecan—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000125	0.000598	CcSEcCtD
Topotecan—Pruritus—Orlistat—type 2 diabetes mellitus	0.000125	0.000595	CcSEcCtD
Topotecan—Fatigue—Losartan—type 2 diabetes mellitus	0.000124	0.000594	CcSEcCtD
Topotecan—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000124	0.00059	CcSEcCtD
Topotecan—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000123	0.000589	CcSEcCtD
Topotecan—Constipation—Losartan—type 2 diabetes mellitus	0.000123	0.000589	CcSEcCtD
Topotecan—Pain—Losartan—type 2 diabetes mellitus	0.000123	0.000589	CcSEcCtD
Topotecan—Rash—Gliclazide—type 2 diabetes mellitus	0.000122	0.000584	CcSEcCtD
Topotecan—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000122	0.000584	CcSEcCtD
Topotecan—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000122	0.000582	CcSEcCtD
Topotecan—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000122	0.000581	CcSEcCtD
Topotecan—Headache—Gliclazide—type 2 diabetes mellitus	0.000121	0.00058	CcSEcCtD
Topotecan—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000121	0.000579	CcSEcCtD
Topotecan—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000121	0.000578	CcSEcCtD
Topotecan—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000121	0.000578	CcSEcCtD
Topotecan—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000121	0.000578	CcSEcCtD
Topotecan—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00012	0.000576	CcSEcCtD
Topotecan—Skin disorder—Ramipril—type 2 diabetes mellitus	0.00012	0.000573	CcSEcCtD
Topotecan—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000119	0.000571	CcSEcCtD
Topotecan—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000119	0.000567	CcSEcCtD
Topotecan—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000118	0.000563	CcSEcCtD
Topotecan—Dizziness—Valsartan—type 2 diabetes mellitus	0.000118	0.000563	CcSEcCtD
Topotecan—Anorexia—Ramipril—type 2 diabetes mellitus	0.000118	0.000563	CcSEcCtD
Topotecan—Dizziness—Orlistat—type 2 diabetes mellitus	0.000116	0.000556	CcSEcCtD
Topotecan—Asthenia—Metformin—type 2 diabetes mellitus	0.000116	0.000556	CcSEcCtD
Topotecan—Nausea—Gliclazide—type 2 diabetes mellitus	0.000115	0.00055	CcSEcCtD
Topotecan—Pruritus—Metformin—type 2 diabetes mellitus	0.000115	0.000548	CcSEcCtD
Topotecan—Urticaria—Losartan—type 2 diabetes mellitus	0.000114	0.000547	CcSEcCtD
Topotecan—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000114	0.000544	CcSEcCtD
Topotecan—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000114	0.000544	CcSEcCtD
Topotecan—Vomiting—Valsartan—type 2 diabetes mellitus	0.000113	0.000541	CcSEcCtD
Topotecan—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000113	0.000539	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000113	0.000538	CcSEcCtD
Topotecan—Rash—Valsartan—type 2 diabetes mellitus	0.000112	0.000537	CcSEcCtD
Topotecan—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000112	0.000536	CcSEcCtD
Topotecan—Vomiting—Orlistat—type 2 diabetes mellitus	0.000112	0.000535	CcSEcCtD
Topotecan—Headache—Valsartan—type 2 diabetes mellitus	0.000112	0.000533	CcSEcCtD
Topotecan—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000111	0.00053	CcSEcCtD
Topotecan—Rash—Orlistat—type 2 diabetes mellitus	0.000111	0.00053	CcSEcCtD
Topotecan—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000111	0.00053	CcSEcCtD
Topotecan—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000111	0.00053	CcSEcCtD
Topotecan—Headache—Orlistat—type 2 diabetes mellitus	0.00011	0.000527	CcSEcCtD
Topotecan—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.00011	0.000526	CcSEcCtD
Topotecan—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00011	0.000525	CcSEcCtD
Topotecan—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000109	0.00052	CcSEcCtD
Topotecan—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000108	0.000518	CcSEcCtD
Topotecan—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000107	0.000513	CcSEcCtD
Topotecan—Dizziness—Metformin—type 2 diabetes mellitus	0.000107	0.000513	CcSEcCtD
Topotecan—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000107	0.00051	CcSEcCtD
Topotecan—Fatigue—Ramipril—type 2 diabetes mellitus	0.000107	0.000509	CcSEcCtD
Topotecan—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000106	0.000507	CcSEcCtD
Topotecan—Nausea—Valsartan—type 2 diabetes mellitus	0.000106	0.000506	CcSEcCtD
Topotecan—Constipation—Ramipril—type 2 diabetes mellitus	0.000106	0.000505	CcSEcCtD
Topotecan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000105	0.000501	CcSEcCtD
Topotecan—Nausea—Orlistat—type 2 diabetes mellitus	0.000105	0.0005	CcSEcCtD
Topotecan—Asthenia—Losartan—type 2 diabetes mellitus	0.000103	0.000494	CcSEcCtD
Topotecan—Vomiting—Metformin—type 2 diabetes mellitus	0.000103	0.000493	CcSEcCtD
Topotecan—Rash—Metformin—type 2 diabetes mellitus	0.000102	0.000489	CcSEcCtD
Topotecan—Dermatitis—Metformin—type 2 diabetes mellitus	0.000102	0.000488	CcSEcCtD
Topotecan—Pruritus—Losartan—type 2 diabetes mellitus	0.000102	0.000487	CcSEcCtD
Topotecan—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000102	0.000486	CcSEcCtD
Topotecan—Headache—Metformin—type 2 diabetes mellitus	0.000102	0.000486	CcSEcCtD
Topotecan—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000101	0.000484	CcSEcCtD
Topotecan—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000101	0.000483	CcSEcCtD
Topotecan—Diarrhoea—Losartan—type 2 diabetes mellitus	9.86e-05	0.000471	CcSEcCtD
Topotecan—Urticaria—Ramipril—type 2 diabetes mellitus	9.81e-05	0.000469	CcSEcCtD
Topotecan—Abdominal pain—Ramipril—type 2 diabetes mellitus	9.77e-05	0.000467	CcSEcCtD
Topotecan—Body temperature increased—Ramipril—type 2 diabetes mellitus	9.77e-05	0.000467	CcSEcCtD
Topotecan—Vomiting—Irbesartan—type 2 diabetes mellitus	9.73e-05	0.000465	CcSEcCtD
Topotecan—Rash—Irbesartan—type 2 diabetes mellitus	9.65e-05	0.000461	CcSEcCtD
Topotecan—Dermatitis—Irbesartan—type 2 diabetes mellitus	9.64e-05	0.000461	CcSEcCtD
Topotecan—Nausea—Metformin—type 2 diabetes mellitus	9.64e-05	0.00046	CcSEcCtD
Topotecan—Headache—Irbesartan—type 2 diabetes mellitus	9.59e-05	0.000458	CcSEcCtD
Topotecan—Dizziness—Losartan—type 2 diabetes mellitus	9.53e-05	0.000455	CcSEcCtD
Topotecan—Vomiting—Losartan—type 2 diabetes mellitus	9.16e-05	0.000438	CcSEcCtD
Topotecan—Hypersensitivity—Ramipril—type 2 diabetes mellitus	9.1e-05	0.000435	CcSEcCtD
Topotecan—Nausea—Irbesartan—type 2 diabetes mellitus	9.09e-05	0.000435	CcSEcCtD
Topotecan—Rash—Losartan—type 2 diabetes mellitus	9.08e-05	0.000434	CcSEcCtD
Topotecan—Dermatitis—Losartan—type 2 diabetes mellitus	9.08e-05	0.000434	CcSEcCtD
Topotecan—Headache—Losartan—type 2 diabetes mellitus	9.03e-05	0.000431	CcSEcCtD
Topotecan—Asthenia—Ramipril—type 2 diabetes mellitus	8.86e-05	0.000424	CcSEcCtD
Topotecan—Pruritus—Ramipril—type 2 diabetes mellitus	8.74e-05	0.000418	CcSEcCtD
Topotecan—Nausea—Losartan—type 2 diabetes mellitus	8.56e-05	0.000409	CcSEcCtD
Topotecan—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.45e-05	0.000404	CcSEcCtD
Topotecan—Dizziness—Ramipril—type 2 diabetes mellitus	8.17e-05	0.00039	CcSEcCtD
Topotecan—Vomiting—Ramipril—type 2 diabetes mellitus	7.85e-05	0.000375	CcSEcCtD
Topotecan—Rash—Ramipril—type 2 diabetes mellitus	7.79e-05	0.000372	CcSEcCtD
Topotecan—Dermatitis—Ramipril—type 2 diabetes mellitus	7.78e-05	0.000372	CcSEcCtD
Topotecan—Headache—Ramipril—type 2 diabetes mellitus	7.74e-05	0.00037	CcSEcCtD
Topotecan—Nausea—Ramipril—type 2 diabetes mellitus	7.34e-05	0.000351	CcSEcCtD
Topotecan—ABCB1—Metabolism—AANAT—type 2 diabetes mellitus	2.63e-05	0.000418	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HK1—type 2 diabetes mellitus	2.62e-05	0.000416	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.56e-05	0.000407	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HSD3B2—type 2 diabetes mellitus	2.53e-05	0.000401	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GCKR—type 2 diabetes mellitus	2.53e-05	0.000401	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LPA—type 2 diabetes mellitus	2.53e-05	0.000401	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—KCNJ11—type 2 diabetes mellitus	2.53e-05	0.000401	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	2.51e-05	0.000399	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CDO1—type 2 diabetes mellitus	2.49e-05	0.000396	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GPD2—type 2 diabetes mellitus	2.49e-05	0.000396	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	2.47e-05	0.000392	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.43e-05	0.000386	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	2.43e-05	0.000386	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALDOB—type 2 diabetes mellitus	2.42e-05	0.000385	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—AKT1—type 2 diabetes mellitus	2.41e-05	0.000382	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.4e-05	0.000381	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AK1—type 2 diabetes mellitus	2.38e-05	0.000378	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	2.32e-05	0.000368	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	2.32e-05	0.000368	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.31e-05	0.000367	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	2.26e-05	0.000359	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GLP1R—type 2 diabetes mellitus	2.25e-05	0.000358	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	2.25e-05	0.000357	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	2.24e-05	0.000355	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC5A4—type 2 diabetes mellitus	2.2e-05	0.000349	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MAT1A—type 2 diabetes mellitus	2.2e-05	0.000349	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.17e-05	0.000344	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	2.15e-05	0.000342	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	2.12e-05	0.000337	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	2.12e-05	0.000337	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.12e-05	0.000337	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	2.12e-05	0.000337	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	2.12e-05	0.000337	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SLC2A2—type 2 diabetes mellitus	2.1e-05	0.000334	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CPT1A—type 2 diabetes mellitus	2.06e-05	0.000327	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—MTR—type 2 diabetes mellitus	2.06e-05	0.000327	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	2.05e-05	0.000326	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	2.05e-05	0.000325	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NAMPT—type 2 diabetes mellitus	2.02e-05	0.000321	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LIPC—type 2 diabetes mellitus	2.01e-05	0.000319	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HBA1—type 2 diabetes mellitus	2.01e-05	0.000319	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GCK—type 2 diabetes mellitus	2.01e-05	0.000319	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP11A1—type 2 diabetes mellitus	2e-05	0.000317	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.97e-05	0.000313	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SLC9A1—type 2 diabetes mellitus	1.96e-05	0.000311	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	1.94e-05	0.000308	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	1.94e-05	0.000308	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CETP—type 2 diabetes mellitus	1.94e-05	0.000308	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	1.9e-05	0.000302	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	1.89e-05	0.0003	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.88e-05	0.000299	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.86e-05	0.000295	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	1.8e-05	0.000286	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	1.8e-05	0.000286	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	1.8e-05	0.000286	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.8e-05	0.000286	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PSMD6—type 2 diabetes mellitus	1.8e-05	0.000286	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SNAP25—type 2 diabetes mellitus	1.8e-05	0.000286	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SREBF1—type 2 diabetes mellitus	1.8e-05	0.000286	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	1.78e-05	0.000282	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CTGF—type 2 diabetes mellitus	1.77e-05	0.000281	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HMGCR—type 2 diabetes mellitus	1.75e-05	0.000278	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	1.73e-05	0.000275	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	1.73e-05	0.000275	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.72e-05	0.000273	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ADRA2A—type 2 diabetes mellitus	1.72e-05	0.000272	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	1.66e-05	0.000264	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	1.66e-05	0.000264	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	1.66e-05	0.000263	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP2E1—type 2 diabetes mellitus	1.65e-05	0.000262	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	1.64e-05	0.00026	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP1A2—type 2 diabetes mellitus	1.63e-05	0.000259	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SLC2A1—type 2 diabetes mellitus	1.63e-05	0.000259	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.62e-05	0.000257	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.62e-05	0.000257	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	1.61e-05	0.000256	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	1.61e-05	0.000255	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	1.61e-05	0.000255	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	1.61e-05	0.000255	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.59e-05	0.000252	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GCG—type 2 diabetes mellitus	1.56e-05	0.000248	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.56e-05	0.000248	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.55e-05	0.000247	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.55e-05	0.000246	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.54e-05	0.000244	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.54e-05	0.000244	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.53e-05	0.000243	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	1.51e-05	0.00024	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.48e-05	0.000235	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.48e-05	0.000235	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.47e-05	0.000233	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.45e-05	0.00023	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	1.42e-05	0.000225	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.39e-05	0.00022	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.38e-05	0.000219	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.37e-05	0.000217	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	1.37e-05	0.000217	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.37e-05	0.000217	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	1.37e-05	0.000217	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.35e-05	0.000215	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.35e-05	0.000215	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.35e-05	0.000214	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GNB3—type 2 diabetes mellitus	1.35e-05	0.000214	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HMOX1—type 2 diabetes mellitus	1.34e-05	0.000213	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CAT—type 2 diabetes mellitus	1.32e-05	0.00021	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.31e-05	0.000208	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.31e-05	0.000208	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.31e-05	0.000208	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.31e-05	0.000208	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.31e-05	0.000208	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.31e-05	0.000208	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—APOB—type 2 diabetes mellitus	1.28e-05	0.000204	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.27e-05	0.000201	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.25e-05	0.000198	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTM1—type 2 diabetes mellitus	1.25e-05	0.000198	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LPL—type 2 diabetes mellitus	1.23e-05	0.000195	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	1.22e-05	0.000193	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ADCY5—type 2 diabetes mellitus	1.2e-05	0.000191	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GPX1—type 2 diabetes mellitus	1.2e-05	0.00019	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.2e-05	0.00019	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.2e-05	0.00019	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.17e-05	0.000186	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.16e-05	0.000185	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CD36—type 2 diabetes mellitus	1.16e-05	0.000185	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.15e-05	0.000183	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.14e-05	0.000181	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	1.11e-05	0.000177	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	1.11e-05	0.000177	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.11e-05	0.000176	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.11e-05	0.000176	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.11e-05	0.000176	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—MTHFR—type 2 diabetes mellitus	1.1e-05	0.000175	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	1.09e-05	0.000174	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	1.09e-05	0.000172	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	1.09e-05	0.000172	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	1.09e-05	0.000172	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPARA—type 2 diabetes mellitus	1.08e-05	0.000172	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.08e-05	0.000171	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.07e-05	0.000169	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.07e-05	0.000169	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.06e-05	0.000168	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AGT—type 2 diabetes mellitus	1.05e-05	0.000167	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	1.05e-05	0.000166	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CALM1—type 2 diabetes mellitus	1.03e-05	0.000164	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.03e-05	0.000163	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—APOE—type 2 diabetes mellitus	1.03e-05	0.000163	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.03e-05	0.000163	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.03e-05	0.000163	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—APOA1—type 2 diabetes mellitus	1.02e-05	0.000161	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.01e-05	0.00016	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	9.91e-06	0.000157	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	9.91e-06	0.000157	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	9.91e-06	0.000157	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	9.74e-06	0.000155	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	9.74e-06	0.000155	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	9.74e-06	0.000155	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	9.56e-06	0.000152	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	9.48e-06	0.00015	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	9.31e-06	0.000148	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	9.29e-06	0.000147	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	9.27e-06	0.000147	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPARG—type 2 diabetes mellitus	8.95e-06	0.000142	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	8.91e-06	0.000141	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	8.81e-06	0.00014	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	8.81e-06	0.00014	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—INS—type 2 diabetes mellitus	8.78e-06	0.000139	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	8.72e-06	0.000138	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	8.59e-06	0.000136	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	8.45e-06	0.000134	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	8.45e-06	0.000134	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	8.42e-06	0.000134	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	8.42e-06	0.000134	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	8.42e-06	0.000134	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	8.42e-06	0.000134	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	8.07e-06	0.000128	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	8.05e-06	0.000128	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	7.7e-06	0.000122	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	7.7e-06	0.000122	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	7.51e-06	0.000119	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	7.28e-06	0.000116	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.28e-06	0.000116	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	7.25e-06	0.000115	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	7.15e-06	0.000114	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	7.04e-06	0.000112	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	7.01e-06	0.000111	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	6.94e-06	0.00011	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	6.87e-06	0.000109	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	6.87e-06	0.000109	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	6.75e-06	0.000107	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	6.73e-06	0.000107	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	6.69e-06	0.000106	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	6.69e-06	0.000106	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	6.69e-06	0.000106	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	6.65e-06	0.000106	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	6.63e-06	0.000105	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	6.53e-06	0.000104	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	6.49e-06	0.000103	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	6.47e-06	0.000103	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	6.46e-06	0.000103	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	6.3e-06	0.0001	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.22e-06	9.87e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	6e-06	9.53e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	6e-06	9.53e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	6e-06	9.53e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	5.97e-06	9.47e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.89e-06	9.35e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	5.85e-06	9.3e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.84e-06	9.27e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.71e-06	9.07e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	5.67e-06	9e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	5.57e-06	8.85e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	5.56e-06	8.82e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	5.49e-06	8.72e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	5.49e-06	8.72e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	5.43e-06	8.62e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	5.43e-06	8.62e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.2e-06	8.26e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.2e-06	8.26e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	4.84e-06	7.68e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—INS—type 2 diabetes mellitus	4.75e-06	7.54e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.48e-06	7.12e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.48e-06	7.12e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.46e-06	7.09e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.4e-06	6.99e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	4.35e-06	6.91e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.28e-06	6.79e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	4.16e-06	6.61e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.16e-06	6.61e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.16e-06	6.61e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.08e-06	6.48e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4e-06	6.35e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.98e-06	6.33e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.88e-06	6.16e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.83e-06	6.08e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	3.81e-06	6.04e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.68e-06	5.84e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.61e-06	5.73e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	3.54e-06	5.62e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.49e-06	5.55e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.43e-06	5.45e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.42e-06	5.43e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.38e-06	5.37e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.98e-06	4.73e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.92e-06	4.64e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.68e-06	4.26e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.56e-06	4.07e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.56e-06	4.07e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.35e-06	3.72e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.91e-06	3.04e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.18e-06	1.87e-05	CbGpPWpGaD
